1. Kojouharova M, Wiersma S, Ivanova T, Filipova R, Ivanova R, Vladimirova N, Teoharov P, Andonov A, Kevorkian A, Stoilova Y, Bakalova S, Bogdanova V, Vazelov E, Mushekov V, Vatcheva R, Savova A, Hasurdjiev S, Tcherveniakova T, Anotonov K, Krivoshiev S, Kunchev A, Troyancheva M, Kurchatova A, Petrova G, Gatcheva N,Galev A, FitzSimons D. Burden and prevention of viral hepatitis in Bulgaria. Viral Hepatitis Prevention Board Meeting, 2011 Mar 24–25; Sofia, Bulgaria.
2. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children
3. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine
4. The use of hepatitis a vaccination in Italy: an economic evaluation